Close mobile menu×
Close mobile menu

Lauren C. Friedlander, MD

Board Certifications: 
Diagnostic Radiology
Expertise in: 
Breast Cancer
Accepting New Patients
Profile Headshot

Appointments

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

Board Certifications

  • Diagnostic Radiology

Clinical Expertise

  • Breast Cancer
  • Breast Ultrasound
  • Breast MRI
  • Breast Biopsy
  • Breast Biopsies
  • Diagnostic Radiology
  • Breast Imaging

Specialties

Education & Training

  • Harvard Medical School
  • Internship: Mount Sinai Medical Center
  • Residency: Hospital of the University of Pennsylvania
  • Fellowship: Memorial Sloan-Kettering Cancer Center

About Lauren Friedlander

Dr. Lauren Friedlander is an assistant professor of radiology at Columbia University Irving Medical Center and an assistant attending radiologist at NewYork-Presbyterian Hospital and NewYork-Presbyterian/Lawrence Hospital. She is board certified in diagnostic radiology and has subspecialty training in breast imaging, having completed a breast and body imaging fellowship at Memorial Sloan Kettering Cancer Center. She completed her diagnostic radiology residency training at the Hospital of the University of Pennsylvania after graduating from Harvard Medical School. She is experienced in all aspects of breast imaging, including mammography, tomosynthesis, breast ultrasound, breast MRI, and breast biopsies. She is a member of the Radiological Society of North America, the American Roentgen Ray Society, the American College of Radiology, the Society of Breast Imaging, the New York Breast Imaging Society, and the New York Roentgen Society.

Academic Titles

  • Assistant Professor of Clinical Radiology

Committee/Societies/Council Memberships

  • New York Breast Imaging Society
  • Society of Breast Imaging
  • New York State Radiological Society
  • Radiological Society of North America
  • American Roentgen Ray Society
  • American College of Radiology

Hospital Affiliations

  • NewYork-Presbyterian/Columbia
  • NewYork-Presbyterian/Lawrence Hospital

Gender

  • Female

Insurance Accepted

For billing questions, please call (866) 815-6994.

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • NYP Employee Plan
  • POS
  • PPO
  • Signature Administrators
  • Student Health

AgeWell

  • Medicare Managed Care
  • Special Needs Plan

Capital District Physician Health Plan

  • Capital District Physician Health Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • EPO
  • Medicare Managed Care
  • PPO

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • MVP Health Care-HMO/EPO (Westchester Only)
  • MVP Health Care-PPO (Westchester Only)

Oxford Health Plans

  • Freedom
  • Liberty

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Research

Selected Publications

Peer-reviewed Articles

  • Goodman S, Mango V, Friedlander L, Desperito E, Wynn R, Ha R. Are mammographically occult additional tumors identified more than 2 cm away from the primary breast cancer on MRI clinically significant? Acad Radiol. 2019; 26 (4): 502-501.
  • Friedlander L, Ha RS. Insights into innovative breast imaging techniques. Clinical Imaging. 2018 Oct. Epub ahead of print.
  • Ha R, Mango V, Al-Khalili R, Mema E, Friedlander L, Desperito E, Wynn RT. Evaluation of association between degree of background parenchymal enhancement on MRI and breast cancer subtype. Clinical Imaging. 2018; 51:307-310.
  • Mango VL, Goodman S, Clarkin K, Wynn RT, Friedlander L, Hibshoosh H, Ha R. The unusual suspects: A review of unusual benign and malignant male breast imaging cases. Clinical Imaging. 2018; 50: 78-85.
  • Patel SN, Mango VL, Jadeja P, Friedlander L, Desperito E, Wynn R, Feldman S, Ha R. Reflector-guided breast tumor localization versus wire localization for lumpectomies: A comparison of surgical outcomes. Clinical Imaging. 2018; 47: 14-17.
  • Ha R, Friedlander LC, Hibshoosh H, Hendon C, Feldman S, Ahn S, Schmidt H, Akens M, Fitzmaurice M, Wilson B, Mango VL. Optical coherence tomography: a novel imaging method for post-lumpectomy breast margin assessment—a multireader study. Acad Radiol. March 2018; 25: 279-287.
  • Jadeja PH, Mango V, Patel S, Friedlander L, Desperito E, Ayala-Bustamante E, Wynn R, Chen-Seetoo M, Taback B, Feldman S, Ha R. Utilization of multiple SAVI SCOUT surgical guidance system reflectors in the same breast: a single-institution feasibility study. Breast J. 2017; 00: 1-4.
  • Mango V, Ha R, Gomberawalla A, Feldman S, Friedlander L, Desperito E, Patel S, Wynn R. Beyond Wires and Seeds:  Reflector Guided Breast Lesion Localization and Excision. Radiology. 2017; 284 (2): 365-71.
  • Anthony MP, Nguyen D, Friedlander L, Mango V, Wynn R, Ha R. Artifacts in Breast Magnetic Resonance Imaging. Curr Probl Diagn Radiol. 2016 Jul-Aug;45(4):271-7.
  • Ha R, Chow D, Mango V, Friedlander L, Wynn R. Bridging the racial gap. National trend in African-American women breast cancer research productivity from 1992 to 2012. Breast J. 2015; 21 (4):442-4.
  • Friedlander LC, Gavenonis S, Roth S. Results of MRI screening for breast cancer in high-risk patients with lobular carcinoma in situ. Radiology. 2011; 261 (2):421-7.
  • Canter LM, Howell E, Torigian D. Chest radiographic and computed tomographic findings of the temporary total artificial heart (TAH-t). J Thorac Imaging. 2008; 23(4):269-271.
  • Ostfeld RS, Roy P, Haumaier W, Canter L, Keesing F, Rowton ED. Sand fly (Lutzomyia vexator) (Diptera: Psychodidae) populations in upstate New York: abundance, microhabitat, and phenology. J Med Entomol. 2004 Jul;41(4):774-8.

Review Articles

  • Canter LM. Anaphylactoid reactions to radiocontrast media. Allergy Asthma Proc. 2005 May/June.

Abstracts and Presentations

  • Mango V, Patel S, Ha R, Gomberawalla A, Feldman S, Friedlander L, Desperito E, Wynn R. Beyond Wires and Seeds:  Reflector Guided Breast Lesion Localization and Excision. To be presented orally at the 102ndannual meeting of the RSNA, November 2016, Chicago.
  • Lyall A, Hao F, Patel S, Mango V, Friedlander L, Wynn R, Ha R. Can breast MRI help predict distant metastasis? Presented orally at the 116th Annual Meeting of the ARRS, April 2016, Los Angeles.
  • Clarkin K, Mango V, Wynn R, Desperito E, Friedlander L. Delivering Bad News: A Guide for Radiologists. Presented electronically at the 116th Annual Meeting of the ARRS, April 2016, Los Angeles.
  • Patel S, Jin B, Mango V, Desperito E, Friedlander L, Wynn R, Ha R. Do Young Women with Dense Breasts Need Pre-op MRI? Presented orally at the 116th Annual Meeting of the ARRS, April 2016, Los Angeles.
  • Ha R, Mango V, Friedlander L, Alkhalili R, Desperito E, Wynn R. Are technical recall rates a reliable quality metric for mammographic positioning? Presented electronically at the 115th Annual Meeting of the ARRS, April 2015, Toronto.
  • Ha R, Jin B, Mango V, Friedlander L, Alkhalili R, Desperito E, Wynn R. Are patients with high breast MRI background parenchymal enhancement at greater risk for breast cancer molecular subtype (HER2+ and Basal) with poor prognosis? Presented electronically at the 115th Annual Meeting of the ARRS, April 2015, Toronto.
  • Ha R, Jin B, Mango V, Alkhalili R, Desperito E, Wynn R. Are patients with high breast MRI background parenchymal enhancement at greater risk for more proliferative (high Ki-67 index) breast cancers? Presented electronically at the 115th Annual Meeting of the ARRS, April 2015, Toronto.
  • Kwak E, Mango V, Patel S, Friedlander L, Wynn R, Ha R. Personalized pre-operative breast MRI: Selecting patients based on breast cancer prognostic factors. Presented orally at the Society of Breast Imaging/American College of Radiology Breast Imaging Symposium April 2015, Orlando.
  • Mema E, Kwak E, Mango V, Friedlander L, Desperito E, Alkhalili R, Wynn R, Ha R. Are patients with high breast MRI background parenchymal enhancement at greater risk for breast cancers with poor prognostic markers. Presented orally at the Society of Breast Imaging/American College of Radiology Breast Imaging Symposium April 2015, Orlando.
  • Mango V, Ha R, Friedlander LC, Hibshoosh H, Wynn RT. Male breast findings: the unusual suspects. Presented at the 100th Annual Meeting of the Radiological Society of North America (RSNA), Chicago, IL, November 2014.
  • Friedlander LC, Lee CH, Comstock CE, Morris EA, Dershaw D. Frequency of unsuspected missed lesions and false-negative rate and MRI-guided core biopsy. Scientific poster presentation, 97th Annual Meeting of the Radiological Society of North America (RSNA), Chicago, IL, November 2011.
  • Friedlander LC, Gavenonis S, Roth S. MRI screening for breast cancer in high-risk patients with lobular carcinoma in situ. Presented at the 96th Annual Meeting of the Radiological Society of North America (RSNA), Chicago, IL, November 28, 2010.
  • Friedlander LC, Gavenonis S, Roth S. MRI screening for breast cancer in high-risk patients with lobular carcinoma in situ. Presented at Grand Rounds at the Hospital of the University of Pennsylvania, Philadelphia, PA. January 26, 2010.